Kiniksa Pharmaceuticals International, plc
KNSA
$33.70
$0.130.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 108.83% | 196.07% | 29.98% | -224.80% | 77.93% |
| Total Depreciation and Amortization | 3.77% | -13.75% | 0.25% | -7.21% | -7.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.32% | 76.18% | 50.90% | -76.00% | 46.72% |
| Change in Net Operating Assets | -204.19% | -92.21% | 266.47% | 156.55% | -215.53% |
| Cash from Operations | 25.83% | 18.93% | 939.45% | -143.27% | 29.62% |
| Capital Expenditure | -66.67% | 48.70% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.77% | -178.55% | 1,131.60% | 86.44% | -282.84% |
| Cash from Investing | 92.47% | -178.94% | 1,128.56% | 86.44% | -283.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 300.79% | 16.91% | -71.07% | 728.28% | -71.58% |
| Repurchase of Common Stock | -396.84% | 28.72% | 78.69% | -106.55% | -244.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 286.49% | 29.23% | -67.98% | 3,857.87% | -104.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.97% | -130.68% | 4,649.08% | 95.47% | -226.21% |